Parabolic Drugs IPO Details

Issue Open Jun 14, 2010
Issue Close Jun 17, 2010
IPO Price ₹75
Face Value ₹10
IPO Size ₹200.00 Cr
Listing At BSE, NSE
IPO Lot Size 80
PARABOLIC DRUGS LIMITED

Our Company was incorporated on February 22,1996 under the Companies Act, 1956, with the Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. For details of change in our Registered Office, see "History and Certain Corporate Matters" on page 129 of the Prospectus. Registered Office: S.C.O. 99-100, Top Floor, Sector 17-B, Chandigarh 160 017, India. Tel: + (91 172) 391 4646; Fax; + (91 172) 391 4645. There has been no change in the name of our Company since incorporation.
Company Secretary and Compliance Officer: Mr. Anil Kumar Email: pdl.ipo@parabolicdrugs.com; Website: www.parabolicdrugs.com

BASIS OF ALLOTMENT

PUBLIC ISSUE OF 2,66,66,667 EQUITY SHARES OF FACE VALUE RS. 10 EACH (THE "EQUITY SHARES") OF PARABOLIC DRUGS LIMITED ("OUR COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF RS. 75 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS. 65 PER EQUITY SHARE) AGGREGATING TO RS. 200,00,00,025 (THE "ISSUE"). THE ISSUE COMPRISES A NET ISSUE OF 2,61,66,667 EQUITY SHARES (THE "NET ISSUE") AND A RESERVATION OF 5,00,000 EQUITY SHARES FOR SUBSCRIPTION BY ELIGIBLE EMPLOYEES (THE "EMPLOYEE RESERVATION PORTION"). THE ISSUE COMPRISES A FRESH ISSUE OF 2,46,40,965 EQUITY SHARES BY OUR COMPANY (THE "FRESH ISSUE") AND AN OFFER FOR SALE OF 20,25,702 EQUITY SHARES ("OFFER FOR SALE") BY BTS "INDIA PRIVATE EQUITY FUND LIMITED AND ALDEN GLOBAL (MAURITIUS) LIMITED (TOGETHER, THE "SELLING SHAREHOLDERS"). THE ISSUE CONSTITUTED 43.09% OF THE FULLY DILUTED POST ISSUE PAID-UP CAPITAL OF OUR COMPANY.

BID OPENED ON

FOR ALL BIDDERS JUNE 14, 2010

BID CLOSED ON

FOR QIB BIDDERS JUNE 16, 2010

FOR RETAIL AND NON-INSTITUTIONAL BIDDERS (INCLUDING ELIGIBLE EMPLOYEES BIDDING IN THE EMPLOYEE RESERVATION PORTION) JUNE 17, 2010

The Equity Shares of the Company are proposed to be listed on Bombay Stock Exchange Limited ("BSE") and the National Stock Exchange of India Limited ("NSE") and the trading is expected to commence on July 1,2010.

THE FACE VALUE PER EQUITY SHARE IS RS.10/-.
THE ISSUE PRICE PER EQUITY SHARE IS RS. 75/- AND IT IS 7.5 TIMES THE FACE VALUE.

The Issue was made through the book building process (the "Book Building Process") wherein up to 50% of the Net Issue was available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"). Further 5% of the QIB Portion was available for allocation on a proportionate basis to Mutual Funds only. The remainder was available for allocation on a proportionate basis to QIBs and Mutual Funds, subject to valid Bids being received from them at or above the Issue Price. Further, not less than 15% of the Net Issue was available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Net Issue was available for allocation on a proportionate basis to Retail Individual Bidders, subject to valid Bids being received at or above the Issue Price. Further, 5,00,000 Equity Shares was made available for allocation on a proportionate basis to the Eligible Employees, subject to valid Bids being received at or above the Issue Price. The Issue received 12,111 applications (after cheque return cases) for 27,436,880 equity shares resulting in 1.029 times subscription. The details of the applications received in the Issue from Qualified Institutional Buyers, Non-Institutional, Retail Individual Investor and Employee categories are as under: (Before technical rejections)

Category No. of Applications No. of Shares No. of times Subscription
Qualified Institutional Buyers 22 19,343,600 1.4785
Non Institutional Investors 27 4,655,600 1.1861
Retail Individual Investors 11,980 3,387,200. 0.3698
Employee 82 50,480 0.1010

Final Demand
A summary of the final demand as per BSE and NSE as on the Bid/Issue Closing date at different bid prices is as under:

Bid Price No. of Shares % to Total Cumulative Total Cumulative % to total
75 9,865,360 34.00844 29,008,560 100.0000
76 880 0.003034 19,143,200 65.99156
77 800 0.002758 19,142,320 65.98852
78 1840 0.006343 19,141,520 65.98576
79 15,040 0.051847 19,139,680 65.97942
80 16,160 0.055708 19,124,640 65.92757
81 800 0.002758 19,108,480 65.87187
82 400 0.001379 19,107,680 65.86911
83 80 0.000276 19,107,280 65.86773
84 320 0.001103 19,107,200 65.86745
85 15,847,040 54.62884 19,106,880 65.86635
CUTOFF 3,259,840 11.23751 3,259,840 11.23751
TOTAL 29,008,560 100.00%

The Basis of Allocation was finalized in consultation with the Designated Stock Exchange, being the Bombay Stock Exchange Limited ("BSE") on June 25,2010

A. Allocation to Employee Investors (After Technical Rejections) includes ASBA Applications

The Basis of Allocation to the Employee Investors, who have bid at cut off and the Issue Price of Rs. 757- per Equity Share, was finalized in consultation with BSE. The category was subscribed 0.0995 times. As per the Prospectus, the spill over portion to the extent of 450,240 equity shares has been added to Retail Category (157,584 Equity Shares), Non Institutional Investof Category (67,536 Equity Shares) and QIB Category (225,120 Equity Shares).The total number of shares allotted in this category is 49,760 Equity Shares to 81 successful applicants. The category-wise details of the Basis of Allocation are as under:

Category No. of
Applns.
% to
total
Total No.of
Shares applied
% to
total
No. of Shares
allotted per applicant
Ratio Total No.
of Shares allotted
80 3 3.70 240 0.48 80 1:1 240
160 6 7.41 960 1.93 160 1:1 960
240 7 8.64 1,680 3.38 240 1:1 1,680
320 5 6.17 1,600 3.22 320 1:1 1,600
400 4 4.94 1,600 3.22 400 1:1 1,600
480 21 25.93 10,080 20.26 480 1:1 10,080
640 2 2.47 1,280 2.57 640 1:1 1,280
720 11 13.58 7,920 15.92 720 1:1 7,920
1 1.23 880 1.77 880 1:1 880
21 25.93 23,520 47.27 .1120 1:1 23,520

B. Allocation to Retail Individual Investors (After Technical Rejections) includes ASBA Applications

The Basis of Allocation to the Retail Individual Investors, who have bid at cut off and the Issue Price of Rs. 75/- per Equity Share, was finalized in consultation with BSE. The category was subscribed 0.356 times. As per the Prospectus, the spill over portion to the extent of 60,03,758 equity shares has been added to Non Institutional Investor Category (1,385,483 Equity Shares), and QIB Category (4,618,275 Equity Shares). The total number of shares allotted in this category is 3,312,160 Equity Shares to 11,663 successful applicants including spill over from Employee Category (157,584 Equity Shares). The category-wise details of the Basis of Allocation are as under:

Category No. of
Applns.
% to
total
Total No. of
Shares applied
% to
total
No. of Shares
allotted per
applicant
Ratio Total No. of
Shares allotted
80 5129 43.98 410,320 12.39 80 1:1 410,320
160 2410 20.66 385,600 11.64 160 1:1 385,600
240 858 7.36 205,920 6.22 240 1:1 205,920
320 632 5.42 202,240 6.11 320 1:1 202,240
400 598 5.13 239,200 7.22 400 1:1 239,200
480 175 1.50 84,000 2.54 480 1:1 84,000
560 312 2.68 174,720 5.28 560 1:1 174,720
640 149 1.28 95,360 2.88 640 1:1 95,360

720

23 0.20 16,560 0.50 720 1:1 16,560
800 134 1.15 107,200 3.24 800 1:1 107,200
880 21 0.18 18,480 0.56 880 1:1 18,480
960 30 0.26 28,800 0.87 960 1:1 28,800
1040 19 0.16 19,760 0.60 1040 1:1 19,760
1120 1101 9.44 1,233,120 37.23 1120 1:1 1,233,120
1200 16 0.14 19,200 0.58 1200 1:1 19200
1280 56 0.48 71,680 2.16 1280 1:1 71680

C. Allocation to Non Institutional Investors (After Technical Rejections) includes ASBA Applications
The Basis of Allocation to the Non Institutional Investors, who have bid at the Issue Price of Rs. 75/- per Equity Share, was finalized in consultation with BSE. The category was subscribed 0.864 times. As per the Prospectus, the spill over portion to the extent of 732,659 equity shares has been added to QIB Category (732,659 Equity Shares). The total number of shares allotted in this category is 4,645,360 Equity Shares to 24 successful applicants including spill over from Employee Category (67,536 Equity Shares) and Retail Category (1,385,483 Equity Shares). The category-wise details of the Basis of Allocation are as under:

Category No. of
Applns.
% to
total
Total No. of
Shares applied
% to
total
No. of Shares
allotted per applicant
Ratio Total No. of
Shares allotted
1200 1 4.17 1,200 0.03 1,200 1:1 1,200
2000 1 4.17 2,000 0.04 2,000 1:1 2,000
2400 2 8.33 4,800 0.10. 2,400 1:1 4,800
3600 1 4.17 3,600 0.08 3,600 1:1 3,600
5040 1 4.17 5,040 0.11 5,040 1:1 5,040
5600 1 4.17 5,600 0.12 5,600 1:1 5,600
6000 1 4.17 6,000 0.13 6,000 1:1 6,000
6800 1 4.17 6,800 0.15 6,800 1:1 6,800
12000 1 4.17 12000 0.26 12000 1:1 12000
23520 1 4.17 23520 0.51 23520 1:1 23520
29440 1 4.17 29440 0.63 29440 1:1 29440
32000 2 4.17 64000 1.38 32000 1:1 64000
40800 2 8.33 81,600 1.76 40,800 1:1 81,600
66640 2 8.33 133,280 2.87 66,640 1:1 133,280
400000 1 4.17 400,000 8.61 400,000 1:1 400,000
533280 1 4.17 533,280 11.48 533,280 1:1 533,280
666640 2 8.33 1,333,280 28.70 666,640 1:1 1,333,280
799920 1 4.17 799,920 17.22 799,920 1:1 799,920
1200000 1 4.17 1,200,000 25.83 1,200,000 1:1 1,200,000

D. Allocation to QIBs (After Technical Rejections) Includes ASBA Applications
Allocation to QIBs has been done on a proportionate basis in consultation with BSE. As per the SEBI regulations, Mutual Funds were initially allotted 5% of the quantum of shares available (932,968 Equity Shares to 11 successful applicant) including spill over from Employee Category (11,256 Equity Shares), Retail Category (230,913 Equity Shares) and Non Institutional Category (36,633 Equity Shares) and other QIBs were allotted the remaining available shares (17,726,419 Equity Shares to 22 successful applicants) including spill over from Employee Category (213,864 Equity Shares), Retail Category (4,387,362 Equity Shares) and Non Institutional Category (696,026 Equity Shares) on proportionate basis,

FIls Fls/Banks MFs VCs Total
8,898,531 3,413,215 2,949,446 3,398,195 18,659,387

The Board of Directors of the company at its Meeting held at Chandigarh, on 26th June 2010 has approved the basis of allocation of shares of the Issue and has allotted the shares to various successful applicants.

The CAN-cum-Refund Orders and allotment advice and notices has been dispatched on June 28,2010 to the address of the investors as registered with the depositories. In case the same is not received within ten days, investors may contact at the address given below. The Refund Orders have been over-printed with the Bank Mandate details as registered, if any, with the depositories. The shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The company is taking steps to get the equity shares admitted for trading on Bombay Stock Exchange Limited and the National Stock Exchange of India Limited within twelve working days from the date of closure of the issue.

Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them in the prospectus dated June 24,2010 ("Prospectus")

INVESTORS PLEASE NOTE
This details of the allocation made would be hosted on the website of Registrars to the Issue, Link Intime India Private Limited at http://www.linkintime.co.in

All future correspondence in this regard may kindly be addressed to the Registrars to the issue quoting full name of the First/ Sole applicant, Serial number of the bid-cum-application form, number of shares bid for, name of the Member of the Syndicate and Place where the bid was submitted and payment details at the address given below:

Link Intime India Private Limited, Unit: Parabolic Drugs Limited

C-13, Pannalal Silk Mills Compound, L.B.S Marg.Bhandup (West), Mumbai - 400 078. Email: pdl.ipo@linkintime.co.in

Place : Chandigarh
Date : June 29,2010
For PARABOLIC DRUGS LIMITED
Sd/-
Anil Kumar
Company Secretary & Compliance officer

Parabolic Drugs IPO Basis of Allotment FAQs

  1. 1. How shares are allotted in Parabolic Drugs IPO?

    Check the basis of allotment document above to know about how the shares are allocated in Parabolic Drugs IPO. Note that there is a separate rule for allotment in each investor category (i.e. Retail, Non-Institutional, Institutional, Employee).
  2. 2. What is Parabolic Drugs IPO basis of allotment status?

    The Parabolic Drugs IPO basis of allotment (published above) tells you how shares are allocated to you in Parabolic Drugs IPO and category wise demand of IPO share.

    Visit the Parabolic Drugs IPO allotment status page to check the number of shares allocated to your application.

  3. 3. What is Parabolic Drugs IPO allotment process?

    Check the basis of allotment document above to know about how the shares are allocated in Parabolic Drugs IPO. Note that there is a separate rule for allotment in each investor category (i.e. Retail, Non-Institutional, Institutional, Employee).

Comments

   I Like It. | Report Abuse








Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App